Latest Reports
Soft Tissue Sarcoma Market
Soft Tissue Sarcoma Market, By Product Type (Chemotherapeutic Agents, Targeted Therapies, Immunotherapies, Radiation Therapy, Surgical Devices, Diagnostic Imaging Equipment, Others), By End-User (Hospitals, Oncology Centers, Ambulatory Surgical Centers, Research Institutes, Home Care Settings, Others), By Soft Tissue Sarcoma Type (Liposarcoma, Leiomyosarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor, Rhabdomyosarcoma, Others), By Treatment Modality (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Combination Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct-to-Consumer, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Novartis AG, Pfizer Inc., Bayer AG, Merck & Co., Inc., GlaxoSmithKline plc, Eli Lilly and Company
Diabetic Kidney Disease (DKD) Market
Diabetic Kidney Disease (DKD) Market, By Therapy Type (Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Agonists, Dual SGLT1/SGLT2 Inhibitors, Mineralocorticoid Receptor Antagonists, Others), By Drug Class (Early-Stage DKD, Moderate DKD, Advanced DKD, End-Stage Renal Disease (ESRD)), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Dialysis Centers, Homecare Settings), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Novo Nordisk A/S, Bayer AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Eli Lilly
Cutaneous T-Cell Lymphoma (CTCL) Market
Cutaneous T-Cell Lymphoma (CTCL) Market, By Type (Prefilled Syringe, Injectable, Lyophilized), By Hematopoietic Stem Cell Transplantation Type (Autologous, Allogeneic), By End-user (Hospitals, Specialty Clinics, Stem Cell Banks, Others), By Combination Therapy (Plerixafor + GCSF, Plerixafor + Chemo + GCSF, Others), By Application (Non-Hodgkin’s Lymphoma, Multiple Myeloma, Hodgkin’s Lymphoma, Acute Myeloid Leukemia, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, Sanofi S.A, Cadila Healthcare, Mylan N.V., IDsA Generics, Cipla Ltd.
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market, By Drug Class (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Disease Indication (Type 2 Diabetes Mellitus, Others), By Patient Demographics (Geriatric Population, Adults, Pediatrics), By End-User (Hospitals, Homecare, Specialty Clinics, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Novartis AG, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
CTLA-4 Inhibitors Market
CTLA-4 Inhibitors Market, By Product Type (Monoclonal Antibodies, Small Molecules, Others), By Indication (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Others), By Route of Administration (Intravenous, Subcutaneous, Oral, Others), By Mechanism of Action (Immune Checkpoint Inhibition, T-Cell Activation, Others), By End User (Hospitals, Clinics, Cancer Research Centers, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Bristol-Myers Squibb, Merck & Co., Roche, AstraZeneca, Pfizer, Novartis, Sanofi
Cough In Idiopathic Pulmonary Fibrosis (IPF) Market
Cough in Idiopathic Pulmonary Fibrosis (IPF) Market, By Drug Class (Anti-fibrotic agents, Immunosuppressants, Corticosteroids, Antioxidants, Others (Mucolytics, Bronchodilators)), By Route of Administration (Oral, Inhalation, Intravenous, Others (Subcutaneous, Intramuscular)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Specialty Pharmacies, Mail Order Pharmacies)), By Disease Subtype (Idiopathic Pulmonary Fibrosis (IPF), Non-IPF Interstitial Lung Diseases (ILDs), Acute Interstitial Pneumonitis, Chronic Hypersensitivity Pneumonitis, Others (Cryptogenic Organizing Pneumonia, Sarcoidosis)), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings, Others (Research Institutes, Academic Institutions)), By Mechanism of Action (Tyrosine Kinase Inhibitors, Antioxidants, Anti-inflammatory Agents, Immunosuppressants, Others (Mucolytics, Bronchodilators)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Roche, Boehringer Ingelheim, Genentech, Fibrogen, Prometic Life Sciences, Galapagos
Connective Tissue Growth Factor (CTGF) Inhibitors Market
Connective Tissue Growth Factor (CTGF) Inhibitors Market, By Product Type (Monoclonal Antibodies, Small Molecule Inhibitors, Antisense Oligonucleotides, Others (Gene Therapies, RNAi-based therapies)), By Therapeutic Area (Idiopathic Pulmonary Fibrosis (IPF), Diabetic Kidney Disease, Liver Fibrosis, Systemic Sclerosis, Cardiac Fibrosis, Others (Skin Fibrosis, Macular Degeneration)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: FibroGen, Inc., Gilead Sciences, Inc., Biogen Inc., Merck & Co., Inc., Roche Holding AG
Complement 3 Glomerulopathy Market
Complement 3 Glomerulopathy Market, By Type (Membranoproliferative Glomerulonephritis (MPGN), Dense Deposit Disease (DDD), C3 Glomerulonephritis (C3GN), Others (including Atypical Hemolytic Uremic Syndrome)), By Treatment Type (Immunosuppressive Therapies, Plasma Therapies, Complement Inhibitors, Gene Therapies, Kidney Transplantation, Others (including symptomatic treatments)), By Route of Administration (Intravenous, Oral, Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others (including research institutes)), By Mechanism of Action (Complement C3 Inhibitors, Complement C5 Inhibitors, Complement Factor B Inhibitors, Others (including anti-inflammatory agents)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Alexion Pharmaceuticals, Chemocentryx, Omeros Corporation, Genentech, Novartis
Complicated Urinary Tract Infections Market
Complicated Urinary Tract Infections Market, By Infection Type (Complicated Pyelonephritis, Complicated Lower UTI, Catheter-associated UTI, Others (Urologic Procedure-associated UTI, Renal Transplant-associated UTI)), By Pathogen Type (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter spp., Proteus spp., Acinetobacter baumannii, Others (Enterococcus spp., Staphylococcus spp.)), By Drug Class (Aminoglycosides, Cephalosporins, Carbapenems, Fluoroquinolones, Others (Polymyxins, Tetracyclines)), By Route of Administration (Intravenous, Oral, Others (Intramuscular, Topical)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Clinics, Medical Stores)), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others (Long-term Care Facilities, Home Healthcare)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG
Complement Inhibitors (C3/C5) Market
Complement Inhibitors (C3/C5) Market, By Product Type (C3 Inhibitors, C5 Inhibitors, C5a Inhibitors, Others (C3a inhibitors, C5b inhibitors, etc.)), By Route of Administration (Intravenous, Subcutaneous, Oral, Others (Intravitreal, Intrathecal, etc.)), By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder (NMOSD), Age-related Macular Degeneration (AMD), Lupus Nephritis, Others (Glomerulonephritis, Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, etc.)), By Mechanism of Action (Terminal Complement Inhibitors, Upstream Complement Inhibitors, Lectin Pathway Inhibitors, Alternative Pathway Inhibitors, Others (Anaphylatoxin inhibitors, Convertase inhibitors, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,Online Pharmacies, Others (Specialty Pharmacies, Mail-order Pharmacies, etc.)), By End-User (Hospitals, Clinics, Homecare Settings, Others (Research Institutes, Academic Organizations, etc.)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Alexion Pharmaceuticals (AstraZeneca), Apellis Pharmaceuticals, Novartis AG